Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01144169
What this trial is testing

Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Pittsburgh 7
Testing effectiveness (Phase 2)Looking for participantsNCT06794229
What this trial is testing

Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis

Who this might be right for
Locally Advanced Renal Cell Carcinoma
Qian Qin 69
Not applicableStudy completedNCT06656039
What this trial is testing

A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma, Clear Cell
RenJi Hospital 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT07226544
What this trial is testing

Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer

Who this might be right for
Localized Clear Cell Renal Cell CarcinomaResectable Clear Cell Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more
City of Hope Medical Center 31
Not applicableStudy completedNCT06317207
What this trial is testing

Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy

Who this might be right for
Renal Cell CarcinomaRobotic Surgical Procedures
The First Affiliated Hospital of Anhui Medical University 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05501054
What this trial is testing

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)WithdrawnNCT00025519
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00626509
What this trial is testing

Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Gruppo Italiano Carcinoma Renale 110
Not applicableStudy completedNCT03161145
What this trial is testing

Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 297
Early research (Phase 1)Ended earlyNCT02543645
What this trial is testing

Varlilumab and Atezolizumab in Patients With Advanced Cancer

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more
Celldex Therapeutics 18
Testing effectiveness (Phase 2)Ended earlyNCT01147536
What this trial is testing

Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence

Who this might be right for
Renal Cell Carcinoma
Agenus Inc. 12
Testing effectiveness (Phase 2)UnknownNCT04049344
What this trial is testing

Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Zhejiang Cancer Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06863311
What this trial is testing

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Karie Runcie 70
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Testing effectiveness (Phase 2)UnknownNCT00862303
What this trial is testing

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fuzhou General Hospital 100
Not applicableUnknownNCT03033186
What this trial is testing

Everolimus TDM to Predict Long Term Toxicity

Who this might be right for
Breast CancerRenal Cell CarcinomaPancreatic Neuroendocrine Tumour+2 more
Maastricht University Medical Center 40
Not applicableStudy completedNCT04883827
What this trial is testing

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
Vanderbilt-Ingram Cancer Center 180
Large-scale testing (Phase 3)Looking for participantsNCT07489495
What this trial is testing

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 758
Testing effectiveness (Phase 2)Study completedNCT02002312
What this trial is testing

Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Radboud University Medical Center 14
Early research (Phase 1)Looking for participantsNCT06553339
What this trial is testing

HS-10516 in Patients With VHL Syndrome Associated Tumors

Who this might be right for
Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd. 60
Next Page